Ian Smith

Ian Smith

Chairman chez SOLID BIOSCIENCES INC.

Fortune : 2 M $ au 31/03/2024

58 ans
Health Technology
Commercial Services
Consumer Services

Profil

Ian Frederick Smith is currently the Executive Chairman at Solid Biosciences, Inc. He is also a Director at Vertex Pharmaceuticals (Canada), Inc., a Director at Vertex Pharmaceuticals (U.K.) Ltd., an Independent Director at Stoke Therapeutics, Inc., a Director at Alkeus Pharmaceuticals, Inc., a Director at iVexSol, Inc., and a Member of the Institute of Chartered Accountants in England & Wales, The American Institute of Certified Public Accountants, and The Financial Executives Institute.
Additionally, he serves as a Senior Advisor at Bain Capital Life Sciences LP and as an Advisor and Director at Foghorn Therapeutics, Inc. Mr. Smith previously held positions as the Executive Chairman at ViaCyte, Inc., a Director at EPIX Pharmaceuticals, Inc., a Director at Tolerx, Inc., an Independent Director at Acorda Therapeutics, Inc., a Director at Predix Pharmaceuticals, Inc., an Independent Director at Infinity Pharmaceuticals, Inc., a Director at Vertex Pharmaceuticals (Europe) Ltd., an Independent Director at IVERIC bio, Inc., and a Co-Managing Director at Vertex Pharmaceuticals (Germany) GmbH.
He was also a Partner-Life Science & Technology Practice Group at Ernst & Young LLP and the EVP, Chief Operating & Financial Officer at Vertex Pharmaceuticals, Inc. Mr. Smith obtained his undergraduate degree from Manchester Metropolitan University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
03/04/2024 103 207 ( 0,27% ) 1 M $ 31/03/2024
29/02/2024 72 072 ( 0,17% ) 483 603 $ 31/03/2024

Postes actifs de Ian Smith

SociétésPosteDébut
SOLID BIOSCIENCES INC. Chairman 16/06/2020
FOGHORN THERAPEUTICS INC. Director/Board Member 27/04/2021
STOKE THERAPEUTICS, INC. Director/Board Member 19/09/2023
Consultant / Advisor -
Director/Board Member -
Corporate Officer/Principal -
The Financial Executives Institute Corporate Officer/Principal 15/07/2011
Corporate Officer/Principal 15/07/2011
Tous les postes actifs de Ian Smith

Anciens postes connus de Ian Smith

SociétésPosteFin
Director/Board Member 01/12/2022
░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Ian Smith

Formation de Ian Smith

Manchester Metropolitan University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ian Smith

Relations

100 +

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées6
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

ACORDA THERAPEUTICS, INC.

Health Technology

INFINITY PHARMACEUTICALS, INC.

Health Technology

SOLID BIOSCIENCES INC.

Health Technology

FOGHORN THERAPEUTICS INC.

Health Technology

STOKE THERAPEUTICS, INC.

Health Technology

Entreprise privées14

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

The Financial Executives Institute

Commercial Services

Distribution Services

Commercial Services

Health Technology

Health Technology

Finance

Health Technology

Voir les connexions sociétés